Various splicing factors, including SRSF2, could be inhibited by telomere dysfunction, leading to altered differentiation in common myeloid progenitor (CMP) and development of classic myelodysplastic syndrome (MDS) phenotype [71]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.